Cambridge Advisors Inc. Becton Dickinson & CO Transaction History

Cambridge Advisors Inc.

$446 Million
Q3 2024

A detailed history of Cambridge Advisors Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Cambridge Advisors Inc. holds 1,727 shares of BDX stock, worth $391,942. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,727

Previous 1,727 -0.0%

Holding current value

$391,942

Previous $403,000 3.23%

% of portfolio

0.09%

Previous 0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$225.07 - $246.17 $157,549 - $172,319	-700 Reduced 28.84%	1,727 $403,000
Q4 2021 Jan 14, 2022	SELL	$230.08 - $250.94 $17,256 - $18,820	-75 Reduced 3.0%	2,427 $610,000
Q3 2020 Oct 15, 2020	SELL	$215.77 - $276.76 $10,788 - $13,838	-50 Reduced 1.96%	2,502 $582,000
Q4 2019 Jan 28, 2020	BUY	$236.45 - $266.82 $603,420 - $680,924	2,552 New	2,552 $694,000
Q3 2019 Oct 25, 2019	SELL	$230.58 - $256.08 $643,779 - $714,975	-2,792 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$217.4 - $246.08 $22,827 - $25,838	-105 Reduced 3.62%	2,792 $704,000
Q4 2018 Jan 29, 2019	SELL	$204.73 - $257.93 $10,236 - $12,896	-50 Reduced 1.7%	2,897 $653,000
Q3 2018 Oct 24, 2018	SELL	$233.07 - $256.0 $16,314 - $17,920	-70 Reduced 2.32%	2,947 $769,000
Q2 2018 Jul 30, 2018	SELL	$208.1 - $233.85 $5,202 - $5,846	-25 Reduced 0.82%	3,017 $723,000
Q1 2018 Apr 18, 2018	SELL	$205.46 - $240.27 $10,273 - $12,013	-50 Reduced 1.62%	3,042 $659,000
Q4 2017 Jan 26, 2018	SELL	$189.0 - $222.64 $13,797 - $16,252	-73 Reduced 2.31%	3,092 $662,000
Q3 2017 Oct 27, 2017	BUY	$186.89 - $198.9 $591,506 - $629,518	3,165	3,165 $620,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Advisors Inc. with notifications on news.

Account

Cambridge Advisors Inc. Becton Dickinson & CO Transaction History